CoChat

Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin

Open access
Haass-Koffler, Carolina L., Goodyear, Kimberly, Zywiak, William H., Magill, Molly, Eltinge, Sarah E., Wallace, Paul M., Long, Victoria M., Jayaram-Lindström, Nitya, Swift, Robert M., Kenna, George A., Leggio, Lorenzo · 2017 · Drug and Alcohol Dependence
Cited by 47

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background Preclinical and clinical research suggest that the α1 receptor antagonist prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role of prazosin in treating Post-Traumatic Stress Disorder (PTSD) symptoms, while a recent trial suggested that pre-treatment blood pressure (BP) predicts therapeutic response for prazosin in PTSD patients. Whether pre-treatment BP may predict response to α1 blockers in alcohol-dependent (AD) patients is unknown. We previously reported a randomized controlled trial (RCT), where doxazosin, an α1 receptor antagonist with a more favorable pharmacokinetic profile than prazosin, reduced drinks per week (DPW) and heavy drinking days (HDD) in AD patients with a high family history density of alcoholism. In this study, we tested pre-treatment BP as another potentially valuable clinical moderator of doxazosin’s response on alcohol consumption. Methods This was a double-blind placebo-controlled RCT testing doxazosin up to 16 mg/day in AD treatment-seeking patients (N = 41). The hypothesized moderator effect of baseline standing systolic and diastolic BP on DPW and HDD was tested. Results With pre-treatment standing diastolic BP as a moderator, there were significant BP × medication interactions for both DPW [**p= 0.009, d = 0.80] and HDD [*p = 0.018, d = 1.11]. Post-hoc analyses indicated significant doxazosin effects in patients with higher standing BP in reducing both DPW and HDD. Conclusion These findings suggest that higher standing diastolic BP at baseline (pre-treatment) may represent a predictor of doxazosin’s response on alcohol consumption in AD patients. These results further elucidate the possible efficacy and mechanisms of action of α1 receptor antagonism in AD individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2017.03.016

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 47

Metadata

Authors
Haass-Koffler, C. L., Goodyear, K., Zywiak, W. H., Magill, M., Eltinge, S. E., Wallace, P. M., Long, V. M., Jayaram-Lindström, N., Swift, R. M., Kenna, G. A., & Leggio, L.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2017-08
Volume
177
Pages
23-28
ISSN
0376-8716 (ISSN-L)
OpenAlex
W2614277232
Cited by
47
References
6
FWCI
3.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2017.03.016
The paper
Haass-Koffler, C. L., Goodyear, K., Zywiak, W. H., Magill, M., Eltinge, S. E., Wallace, P. M., Long, V. M., Jayaram-Lindström, N., Swift, R. M., Kenna, G. A., & Leggio, L. (2017). Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2017.03.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.